257 related articles for article (PubMed ID: 21774711)
1. Mutual antagonism of T cells causing psoriasis and atopic eczema.
Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
N Engl J Med; 2011 Jul; 365(3):231-8. PubMed ID: 21774711
[No Abstract] [Full Text] [Related]
2. [Psoriasis or atopic eczema: skin-infiltrating effector memory T cells make the difference].
Homey B
Hautarzt; 2012 Jan; 63(1):52. PubMed ID: 22212158
[No Abstract] [Full Text] [Related]
3. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.
Ghoreschi K; Thomas P; Breit S; Dugas M; Mailhammer R; van Eden W; van der Zee R; Biedermann T; Prinz J; Mack M; Mrowietz U; Christophers E; Schlöndorff D; Plewig G; Sander CA; Röcken M
Nat Med; 2003 Jan; 9(1):40-6. PubMed ID: 12461524
[TBL] [Abstract][Full Text] [Related]
5. The T-helper1/T-helper2 paradigm: still valid for drug discovery but with some essential refinement.
Korstanje C
Curr Opin Investig Drugs; 2004 May; 5(5):487-8. PubMed ID: 15202720
[No Abstract] [Full Text] [Related]
6. [Subpopulations of peripheral T lymphocytes (Th/Ts) in atopic dermatitis and in psoriasis].
Klene U; Gollnick H; Bauer R; Orfanos CE
Hautarzt; 1986 Jan; 37(1):17-22. PubMed ID: 2936698
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis.
Cohen JN; Bowman S; Laszik ZG; North JP
J Am Acad Dermatol; 2020 Feb; 82(2):430-439. PubMed ID: 31859047
[TBL] [Abstract][Full Text] [Related]
10. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis.
Breuer K; Wittmann M; Kempe K; Kapp A; Mai U; Dittrich-Breiholz O; Kracht M; Mrabet-Dahbi S; Werfel T
Clin Exp Allergy; 2005 Aug; 35(8):1088-95. PubMed ID: 16120092
[TBL] [Abstract][Full Text] [Related]
11. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
[TBL] [Abstract][Full Text] [Related]
12. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.
Eyerich K; Novak N
Allergy; 2013 Aug; 68(8):974-82. PubMed ID: 23889510
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
[TBL] [Abstract][Full Text] [Related]
14. Extra domain A-positive fibronectin-positive feedback loops and their association with cutaneous inflammatory disease.
McFadden JP; Basketter DA; Dearman RJ; Kimber IR
Clin Dermatol; 2011; 29(3):257-65. PubMed ID: 21496732
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 4 treatment of psoriasis: are pleiotropic cytokines suitable therapies for autoimmune diseases?
Martin R
Trends Pharmacol Sci; 2003 Dec; 24(12):613-6. PubMed ID: 14654299
[TBL] [Abstract][Full Text] [Related]
16. Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes.
Yasukawa S; Dainichi T; Kokuba H; Moroi Y; Urabe K; Hashimoto T; Furue M
Eur J Dermatol; 2009; 19(1):69-71. PubMed ID: 19059833
[TBL] [Abstract][Full Text] [Related]
17. T-helper immune phenotype may underlie 'paradoxical' tumour necrosis factor-α inhibitor therapy-related psoriasiform dermatitis.
Moy AP; Murali M; Kroshinsky D; Horn TD; Nazarian RM
Clin Exp Dermatol; 2018 Jan; 43(1):19-26. PubMed ID: 28940220
[TBL] [Abstract][Full Text] [Related]
18. [Psoriasis syndrome with its comorbidities].
Piérard-Franchimont C; Piérard GE; Delvenne P; Hermanns-Lê T
Rev Med Liege; 2014 Oct; 69(10):555-8. PubMed ID: 25796750
[TBL] [Abstract][Full Text] [Related]
19. Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.
Ishiuji Y; Umezawa Y; Asahina A; Fukuta H; Aizawa N; Yanaba K; Nakagawa H
J Dermatol; 2018 Jun; 45(6):732-734. PubMed ID: 29569296
[TBL] [Abstract][Full Text] [Related]
20. [The immune response against microbial infections in the skin--weak in atopic dermatitis and strong in psoriasis].
Palatsi R; Hägg P
Duodecim; 2011; 127(2):127-34. PubMed ID: 21442863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
